Research And Markets Research And Markets
0 CHECKOUT

Global Asset Purchase Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010 to 2016

  • ID: 2624227
  • May 2016
  • Region: Global
  • 929 Pages
  • CurrentPartnering
1 of 3

The Global Asset Purchase Deals in Pharma, Biotech and Diagnostics 2010-2016 report provides a detailed understanding and analysis of how and why companies enter business, product, technology and royalty assets.

The report provides a detailed understanding and analysis of how and why companies enter business, product, technology and royalty assets.

The focus of the report is on partnerships for business, product, technology and royalty assets where partners have entered an agreement to dispose of or acquire said assets.

Companies may seek to dispose of an asset simply because it is surplus to requirements. Or it may seek to dispose of assets in order to raise funds to invest in others parts of its business. Or it may be due to a regulatory requirement to dispose of certain business or product assets as a result of a pending business merger in order to meet competition regulations.

The report provides access to asset purchase deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.

The report focuses on four primary types of asset available for purchase:

Business assets - the most common asset exchanging hands. Business assets are in the form of a business unit or subsidiary READ MORE >

Note: Product cover images may vary from those shown
2 of 3

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Asset Purchase dealmaking

2.1. Introduction
2.2. Types of assets purchased
2.3. Trends in Asset Purchase deals since 2010
2.3.1. Asset Purchase dealmaking by year, 2010 to 2016
2.3.2. Asset Purchase dealmaking by phase of development, 2010 to 2016
2.3.3. Asset Purchase dealmaking by industry sector, 2010 to 2016
2.3.4. Asset Purchase dealmaking by therapy area, 2010 to 2016
2.3.5. Asset Purchase dealmaking by technology type, 2010 to 2016
2.3.6. Asset Purchase dealmaking by most active company, 2010 to 2016
2.4. Reasons for entering into asset purchase partnering deals
2.4.1. Business assets
2.4.2. Product assets
2.4.3. Royalty assets
2.4.4. Technology assets
2.5 The emergence of royalty asset purchase deals
2.5.1. Primary players in royalty asset purchase deals
2.5.3. The future of royalty asset purchase deals
2.6. The role of IP auction houses in asset purchase deals
2.6.1. Leading IP auction companies
2.7. The future of asset purchase agreements

Chapter 3 - Overview of Asset Purchase deal structure

3.1. Introduction
3.2. Asset purchase agreement structure
3.3. Example asset purchase agreements
3.3.1. Case study 1: Product asset: QLT - Valeant Pharmaceuticals
3.3.2. Case study 2: Business asset: Merck and Co - Bayer
3.4. Anatomy of a royalty asset purchase agreement
3.5. Example royalty asset purchase agreements
3.5.1. Case study 3: Royalty asset: BioTime Acquisition Corporation- Geron Corporation

Chapter 4 - Leading Asset Purchase deals

4.1. Introduction
4.2. Top Asset Purchase deals by value

Chapter 5 - Top 50 most active Asset Purchase dealmakers

5.1. Introduction
5.2. Top 50 most active Asset Purchase dealmakers

Chapter 6 - Asset Purchase deals including contracts directory

6.1. Introduction
6.2. Asset Purchase deals with contracts 2010 to 2016

Appendices

Appendix 1 - Asset Purchase dealmaking by companies A-Z
Appendix 2 - Asset Purchase dealmaking by industry sector
Appendix 3 - Asset Purchase dealmaking by stage of development
Appendix 4 - Asset Purchase dealmaking by therapy area
Appendix 5 - Asset Purchase dealmaking by technology type

About

Table of Figures

Figure 1: Definition of assets purchased
Figure 2: Trends in Asset Purchase deal announcements, 2010 to 2016
Figure 3: Asset Purchase deals signed at each phase of development, 2010 to 2016
Figure 4: Asset Purchase deals by industry sector, 2010 to 2016
Figure 5: Asset Purchase deals by therapy area, 2010 to 2016
Figure 6: Asset Purchase deals by technology type, 2010 to 2016
Figure 7: Top 50 most active Asset Purchase dealmakers, 2010 to 2016
Figure 8: Leading royalty asset investors
Figure 9: Leading IP auction companies
Figure 10: Components of the asset purchase deal structure
Figure 11: Components of the royalty asset purchase deal structure
Figure 12: Top Asset Purchase deals by value 2010 to 2016
Figure 13: Most active Asset Purchase dealmakers 2010 to 2016

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown

RELATED PRODUCTS from Db